Aclaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research.

Medical - Diagnostics & Research
US, Wayne [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Aclaris Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Aclaris Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Aclaris Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of ACRS's Analysis
CIK: 1557746 CUSIP: 00461U105 ISIN: US00461U1051 LEI: - UEI: -
Secondary Listings
ACRS has no secondary listings inside our databases.